While no studies have carefully examined the interferon-beta responses in the hippocampal region of BCAS-hypoperfusion mice so far, activation of IFN-related signaling pathways has been confirmed in multiple rodent models of neurological disorders (Kong et al. 2022; Harmon et al. 2022). The gene discussed is IFNB1; the disease is nervous system disorder.